 Shares of Eloxx Pharmaceuticals OTCMKTS:ELOX have earned a consensus rating of Buy from the six analysts that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average twelve-month target price among brokerages that have issued ... 